Biogen Calls for US Policymakers to Take Bold Climate Action

Biogen Calls for US Policymakers to Take Bold Climate Action

tweet me:
To mark the 5th anniversary of the #ParisAgreement, @Biogen signed a declaration from @wearestillin calling for US policymakers to join business leaders in taking bold #climateaction. Learn more about Biogen's science-based #climate commitments: https://bit.ly/2KcLaqY
Friday, December 18, 2020 - 10:30am

CONTENT: Multimedia with summary

To mark the 5th anniversary of the Paris Agreement, Biogen signed a declaration from We Are Still In calling for US policymakers to join business leaders in taking bold climate action.

Learn more about our science-based climate commitments

About Biogen
At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing research programs in multiple sclerosis and neuroimmunology, Alzheimer’s disease and dementia, neuromuscular disorders, movement disorders, ophthalmology, immunology, neurocognitive disorders, acute neurology and pain.

We routinely post information that may be important to investors on our website at www.biogen.com. Follow us on social media – TwitterLinkedInFacebookYouTube.

CATEGORY: Environment